Literature DB >> 11684288

Aleukemic granulocytic sarcoma with AML1/ETO fusion gene expression and clonal T cell populations.

J Schwarz1, Z Trnková, R Bedrlíková, A Jirásek, D Záková, M Trnený, E Sedlácková, D Kodetová, J Valenta, P Stöckbauer, C Haskovec, J Soukup.   

Abstract

We report a unique case of aleukemic granulocytic sarcoma of the neck, originally misdiagnosed as non-Hodgkin's lymphoma (NHL), though chloroma was also suspected due to a greenish macroscopic appearance and the presence of myeloid chloroacetate esterase (CAE)+ cells. The proof of clonal T cell receptor gamma chain (TcRgamma) gene rearrangements in the recurring tumor was deemed to confirm the initial diagnosis of T cell NHL. Altogether five distinct types of clonal TcRgamma gene rearrangements were found in the tumor, bone marrow and peripheral blood. Only retrospectively, using RT-PCR, did we detect the acute myeloid leukemia subset-specific fusion gene AML1/ETO in the frozen samples of the relapsed tumor, as well as in the otherwise unaffected bone marrow and peripheral blood (representing 'minimal initial disease' in the latter two samples). Simultaneous staining verified that the neoplastic CAE+ cells and CD45RO+ T cells were different populations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11684288     DOI: 10.1016/s0145-2126(01)00086-8

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  2 in total

1.  Cardiac granulocytic sarcoma diagnosed by intracardiac echocardiography-guided biopsy.

Authors:  Mirta Koželj; Darko Zorman; Blaž Mrevlje; Peter Černelč; Samo Zver
Journal:  Int J Hematol       Date:  2008-05-24       Impact factor: 2.490

2.  Aleukemic extramedullary T lymphoid/myeloid bilineage hematopoietic and lymphoid malignancy with progression to bilineage leukemia at relapse: A case report.

Authors:  Mengyao Wu; Xiaoqiu Li; Feng Tang; Ping Zhu; Tianling Ding; Yan Yuan; Tong Chen
Journal:  Oncol Lett       Date:  2017-10-18       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.